RFB, look I have not always have pom pom's waving on this trade. Let's back up for a second and take a intelligent look into this. First of all throw all of the technical out the window unless your looking at break out spots and support on volume, everything else don't apply. It's a small biotech that holds a lot of patents on a good application with LDN CAN'T DENY THAT, even me. With most of these small co's that needto take financing that is sometimes a tough pill to swallow but I haven't yet seen where there has been a financing that was a total spiral slap in the face. My hunch is that with some of the deals that were cut to either settle lawsuits and or previous employee compensation has come to roost. To that end if you are a believer that the LDN story is good and that the FIDSON and NAFDAC stories are legit, and we haven't come up with definitively yet they are not, then this could be one of the best trades you can add to at these levels. Even if it does get back to .75-1.00 and you sell it at .30 you've done well and will kick yourself that you didn't participate. If you think about how much paper is out there, they have a base of long term players otherwise this would be way worse. The point being is that potentially this is very cheap.
News 
Market Data 
Discover 
